3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Sarcoma
2
Esophageal Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thoracic Diseases
1
Skin Neoplasms
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Paraproteinemias
1
Pancreatic Ductal Adenocarcinoma
1
Nervous System Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Lung Neoplasms
1
Leiomyosarcoma
1
Immunoglobulin Light-chain Amyloidosis
1
Gigantism
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Combined Pituitary Hormone Deficiency
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Central Nervous System Neoplasms
1
Central Nervous System Diseases
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
8
Nivolumab
6
Ipilimumab
6
cemiplimab
4
aldesleukin
3
Interleukin-2
3
fludarabine
2
Specimen Handling
2
Niacinamide
2
HhAntag691
2
Cyclophosphamide
2
Blood Specimen Collection
2
Biopsy
2
trametinib
1
spartalizumab
1
sonidegib
1
pertuzumab
1
lifileucel
1
four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate)
1
fludarabine phosphate
1
dabrafenib
1
brodalumab
1
atezolizumab
1
Vitamin A
1
Trastuzumab
1
Tissue Banks
1
Surgical Procedures, Operative
1
Sunscreening Agents
1
Standard of Care
1
Second Harmonic Generation Microscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Skin Neoplasms
×
Tissue Banks
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled